Delivra's Dream Water(R) Brand Expands Global Footprint with Launch of 6-Count Sleep Gummies into the Gulf Cooperation Council (GCC) Market
Vancouver, British Columbia--(Newsfile Corp. - August 7, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company in the health and wellness sector, is pleased to announce the upcoming launch of its new convenient 6-Count Sleep Gummies in key Middle Eastern markets in collaboration with its distribution partner in Saudi Arabia. This expansion will focus on the Gulf Cooperation Council (GCC) region, a high-gr
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-08-07 5:15 PM EDT | Delivra Health Brands Inc.
PharmaCielo Announces Issuance of Cease Trade Order
Ontario and Rionegro, Colombia--(Newsfile Corp. - August 6, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that the Ontario Securities Commission (the "OSC"), as it
2025-08-06 9:30 AM EDT | PharmaCielo Ltd.
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring CardiolRx™ over placebo. Reduction in ECV was associated with improvements across multiple pre-specified cardiac magnetic resonance imaging (CMR) endpoints, including a significant reduction in LV mass. The ARCHER trial results provide compelling clinical proof of conce
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-08-06 7:27 AM EDT | Cardiol Therapeutics Inc.
Flora Growth Corp. Announces 1-for-39 Share Consolidation
Fort Lauderdale, Florida--(Newsfile Corp. - July 31, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company"), today announced that it will effect a 1-for-39 share consolidation of the Company's issued and outstanding common shares (the "Share Consolidation"). The Share Consolidation will be effective at 5:00 p.m. Eastern Time on August 3, 2025. The Company's common shares (the "Common Shares") are expected to begin trading on The Nasdaq Capital Market on a post-Share
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-07-31 8:01 AM EDT | Flora Growth Corp.
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), announces that the original news release captioned "PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc." published on July 30, 2025 referred, incorrectly, to the number of common shares of PharmaDrug to be issued in the second tranche of the proposed transaction and the total number of shares to be issued pursuant to both tranches. The
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-30 11:37 AM EDT | PharmaDrug Inc.
Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce that its CEO, Tod
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-30 8:05 AM EDT | Red Light Holland Corp.
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is announcing that it has entered into a non-binding Letter of Intent ("LOI") on July 23rd, 2025 to acquire up to a 40% equity interest in Canurta Limited Partnership ("Canurta"), the parent entity of Canurta In
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-07-30 7:30 AM EDT | PharmaDrug Inc.
Delota Reports Annual Audited Results for the Fourteen Months Ended March 31, 2025
Highlights: Total revenue of $46.5 million for the Fourteen Months Ended 2025 38% gross profit margin for the Fourteen Months Ended 2025 Positive Adjusted EBITDA of $1.2 million for the Fourteen Months Ended 2025 Segmented revenue for the Fourteen Months Ended 2025: Vape - B2C: $36.4 million, B2B: $6.0 million Cannabis - B2C: $4.1 million
Retail, Cannabis, Health, Cannabis Dispensary
2025-07-30 7:30 AM EDT | Delota Corp.
MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders
Saskatoon, Saskatchewan--(Newsfile Corp. - July 30, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the following: (i) a non-brokered private placement of up to 4,285,715 units of the Company (each, a "Unit") at a price of $0.70 per Unit for gross proceeds of up to $3,000,000 (the "LIFE Offering"); (ii) the proposed repricing of outstanding share pur
Agriculture, Biotechnology, Cannabis, Cannabis Breeder
2025-07-30 7:00 AM EDT | MustGrow Biologics Corp.
Red Light Holland Reports 2025 Audited Year-End Results - Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion
Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, is pleased to report its Audited Annual Cons
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-29 7:30 AM EDT | Red Light Holland Corp.
CORRECTION FROM THE SOURCE: FloraWorks Highlights New Study Showing CBN Reverses Cognitive Decline in Aging Mice
Portland, Oregon--(Newsfile Corp. - July 28, 2025) - FloraWorks, a developer of high-purity rare cannabinoid ingredients, is drawing attention to new peer-reviewed research demonstrating that Cannabinol (CBN) can reverse cognitive decline in aging mice. The study, publis
Technology, Cannabis, Health, Cannabis Manufacturer
2025-07-28 12:15 PM EDT | FloraWorks
Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A
Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-28 9:19 AM EDT | Red Light Holland Corp.
Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker
Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws today announced its selection of Arch Pub
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-07-25 8:33 AM EDT | Red Light Holland Corp.
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
ARCHER is designed to assess the impact of CardiolRx™ on cardiac magnetic resonance imaging parameters that measure heart dysfunction and edema/fibrosis-key measurements used to predict prognosis in myocarditis patients. Acute myocarditis is a potentially life-threatening condition affecting the heart muscle (myocardium) and is characterized by chest pain, shortness of breath, fatigue, rapid or irregular heartbeat (arrhythm
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-07-22 7:27 AM EDT | Cardiol Therapeutics Inc.